Physician profile
David M Scherer
NPI 1467482083
$1,074.91
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $205 · 2020: $79.52 · 2021: $357 · 2022: $327 · 2023: $92.27 · 2024: $13.93.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $71.93.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $71.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $242.71 | 2019-2023 | |
| Abbott Laboratories | $137.82 | 2021-2022 | |
| Medtronic, INC. | $137.35 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $128.37 | 2019-2022 | |
| Pfizer INC. | $58.29 | 2021-2022 | |
| Medtronic Vascular, INC. | $57.97 | 2019-2020 | |
| Astellas Pharma US INC | $40.33 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $31.70 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $28.89 | 2022 | |
| Amarin Pharma, INC. | $24.69 | 2019 | |
| Heartflow, INC. | $23.41 | 2019 | |
| Ge Healthcare | $21.82 | 2020 | |
| Novo Nordisk INC | $19.99 | 2022 | |
| Esperion Therapeutics, INC. | $17.00 | 2021 | |
| Sanofi-Aventis U.S. LLC | $16.11 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $15.19 | 2020 | |
| Allergan, INC. | $14.02 | 2019 | |
| Amgen INC. | $13.11 | 2019 | |
| Angiodynamics, INC. | $11.87 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Scherer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.